共 20 条
- [2] Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study [J]. LANCET ONCOLOGY, 2015, 16 (02) : 187 - 199
- [7] EGFR point mutation confers resistance to gefitinib in a patient with non-small-cell lung cancer [J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (06): : 296 - 297
- [10] Eph as a Target in Inflammation [J]. ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2015, 15 (02) : 119 - 128